- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2000
- Business Model
- B2B
- Website
- meipharma.com
- Total Funding
- $202.5M
- Last Round
- $100.0M Private EquityJul 2025
- Rounds
- 3
- Type
- Public
About
MEI Pharma (Nasdaq: MEIP) is a clinical-stage pharmaceutical company committed to developing novel and differentiated cancer therapies. The company leverages its extensive oncology expertise to advance a portfolio of small-molecule drug candidates targeting treatment-resistant cancers, with the goal of improving outcomes for patients with unmet medical needs.
Summary
MEI Pharma is a Biotech company based in San Diego, United States, founded in 2000. It has raised $202.5M in total across 3 rounds, most recently a $100.0M Private Equity round in Jul 2025. Investors include Vivo Capital, Charlie Lee and GSR.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform